Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. SC 13G Stake Amended Statement of Ownership
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 8-K Event Material agreement · Other events
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 8-K Event Results of operations
  10. SC 13G Stake Amended Statement of Ownership
  11. 8-K Event Other events
  12. 4 Shares withheld for taxes EVP,Finance & Strategy and CFO gave up 2,114 shares (to pay taxes)
  13. 4 Shares withheld for taxes SVP, Gen. Counsel & Secretary gave up 1,131 shares (to pay taxes)
  14. 4 Shares withheld for taxes President and COO gave up 3,654 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Executive Officer gave up 6,749 shares (to pay taxes)
  16. 8-K Event Executive or director change
  17. 4 Option exercise President and COO acquired 1,001 shares (option exercise)
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. 4 Grant or award Director acquired 1,431 shares (grant or award)

Page 31 of 115 · 2,300 filings